Fusidic Acid/Betamethason Dermapharm 20 mg/g - 1 mg/g cream

Country: Belgium

Language: English

Source: AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

Active ingredient:

Fusidic Acid Hemihydrate 20,4 mg/g - Eq. Fusidic Acid 20 mg/g; Betamethasone Valerate 1,214 mg/g - Eq. Betamethasone 1 mg/g

Available from:

Dermapharm AG

ATC code:

D07CC01

INN (International Name):

Fusidic Acid Hemihydrate; Betamethasone Valerate

Dosage:

20 mg/g - 1 mg/g

Pharmaceutical form:

Cream

Composition:

Fusidic Acid Hemihydrate 20.4 mg; Betamethasone Valerate 1.214 mg/g

Administration route:

Cutaneous use

Therapeutic area:

Betamethasone and Antibiotics

Product summary:

CTI code: 537671-01 - Pack size: 5 g - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 537671-03 - Pack size: 30 g - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 537671-02 - Pack size: 15 g - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 537671-04 - Pack size: 60 g - Commercialisation status: NO - Delivery mode: Medical prescription

Authorization status:

Commercialised: No

Authorization date:

2019-01-03